Thu, March 2, 2023
Wed, March 1, 2023
Tue, February 28, 2023

Serge Belanger Reiterated (ARQT) at Strong Buy and Held Target at $46 on, Mar 1st, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-46-on-mar-1st-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Serge Belanger of Needham, Reiterated "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy and Held Target at $46 on, Mar 1st, 2023.

Serge, nor any peers, have made any analyst calls on ARQT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources